Modification of pro-inflammatory signaling by dietary components: The plasma membrane as a target

BioEssays

Volumn 37, Issue 7, 2015, Pages 789-801

  Ciesielska, Anna ^a   Kwiatkowska, Katarzyna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Cholesterol; Lipopolysaccharide; Polyphenols; Polyunsaturated fatty acids; Raft domains; Toll like receptor 4; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL; FATTY ACID; LIPOPOLYSACCHARIDE; POLYPHENOL DERIVATIVE; TOLL LIKE RECEPTOR 4; AUTACOID; FAT INTAKE; TLR4 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DIET; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; LIPID COMPOSITION; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; FAT INTAKE; METABOLISM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTIOXIDANTS; CELL MEMBRANE; DIET; DIETARY FATS; HUMANS; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84931956965     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201500017     Document Type: Article

References (120)

1. Michelsen KS, Wong MH, Shah PK, Zhang W, et al. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101: 10679-84.
2. Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, et al. 2011. Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31: 50-7.
3. Poltorak A, He X, Smirnova I, Liu MY, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-8.
4. Wong SW, Kwon M-J, Choi AMK, Kim H-P, et al. 2009. Fatty acids modulate Toll-like Receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 284: 27384-92.
5. Zhu X, Owen JS, Wilson MD, Li H, et al. 2010. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 51: 3196-206.
6. Józefowski S, Czerkies M, Łukasik A, Bielawska A, et al. 2010. Ceramide and ceramide 1-phosphate are negative regulators of TNF-α production induced by lipopolysaccharide. J Immunol 185: 6960-73.
7. Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science 327: 46-50.
8. Kusumi A, Fujiwara TK, Morone N, Yoshida KJ, et al. 2012. Membrane mechanisms for signal transduction: the coupling of the meso-scale raft domains to membrane-skeleton-induced compartments and dynamic protein complexes. Semin Cell Dev Biol 23: 126-44.
9. Płóciennikowska A, Hromada-Judycka A, Borzęcka K, Kwiatkowska K. 2014. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 72: 557-81
10. Pfeiffer A, Böttcher A, Orsó E, Kapinsky M, et al. 2001. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 31: 3153-64.
11. Triantafilou M, Morath S, Mackie A, Hartung T, et al. 2004. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 117: 4007-14.
12. Brügger B. 2014. Lipidomics: analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry. Annu Rev Biochem 83: 79-98.
13. Calder PC, Yaqoob P, Harvey DJ, Watts A, et al. 1994. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 300: 509-18.
14. Sahl SJ, Leutenegger M, Hilbert M, Hell SW, et al. 2010. Fast molecular tracking maps nanoscale dynamics of plasma membrane lipids. Proc Natl Acad Sci USA 107: 6829-34.
15. Mueller V, Ringemann C, Honigmann A, Schwarzmann G, et al. 2011. STED nanoscopy reveals molecular details of cholesterol- and cytoskeleton-modulated lipid interactions in living cells. Biophys J 101: 1651-60.
16. Suzuki KGN, Kasai RS, Hirosawa KM, Nemoto YL, et al. 2012. Transient GPI-anchored protein homodimers are units for raft organization and function. Nat Chem Biol 8: 774-83.
17. Van Zanten TS, Gómez J, Manzo C, Cambi A, et al. 2010. Direct mapping of nanoscale compositional connectivity on intact cell membranes. Proc Natl Acad Sci USA 107: 15437-42.
18. Magenau A, Owen DM, Yamamoto Y, Tran J, et al. 2015. Discreet and distinct clustering of five model membrane proteins revealed by single molecule localization microscopy. Mol Membr Biol 14: 1-8.
19. Chaudhuri A, Bhattacharya B, Gowrishankar K, Mayor S, et al. 2011. Spatiotemporal regulation of chemical reactions by active cytoskeletal remodeling. Proc Natl Acad Sci USA 108: 14825-30.
20. Gowrishankar K, Ghosh S, Saha S, Rumamol C, et al. 2012. Active remodeling of cortical actin regulates spatiotemporal organization of cell surface molecules. Cell 149: 1353-67.
21. Motshwene PG, Moncrieffe MC, Grossmann JG, Kao C, et al. 2009. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284: 25404-11.
22. Kawai T, Akira S. 2011. Toll-like Receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-50.
23. Zanoni I, Ostuni R, Capuano G, Collini M, et al. 2009. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460: 264-8.
24. Kim HM, Park BS, Kim J-I, Kim SE, et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-17.
25. Treeby M, Vasl J, Ota P, Friedrich J, et al. 2009. Different functional role of domain boundaries of Toll-like receptor 4. Biochem Biophys Res Commun 381: 65-9.
26. Simons K, Sampaio JL. 2011. Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol 3: a004697.
27. Lee AG. 2004. How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta 1666: 62-87.
28. Lundbæk JA, Collingwood SA, Ingólfsson HI, Kapoor R, et al. 2010. Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes. J R Soc Interface 7: 373-95.
29. Anderson RGW, Jacobson K. 2002. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296: 1821-5.
30. Lagu T, Rothberg MB, Shieh M-S, Pekow PS, et al. 2012. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 40: 754-61.
31. Sakr Y, Madl C, Filipescu D, Moreno R, et al. 2008. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med 34: 1999-2009.
32. Akinnusi ME, Pineda LA, El Solh AA. 2008. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 36: 151-8
33. Nasraway SA, Albert M, Donnelly AM, Ruthazer R, et al. 2006. Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med 34: 964-70.
34. Rivera CA, Gaskin L, Singer G, Houghton J, et al. 2010. Western diet enhances hepatic inflammation in mice exposed to cecal ligation and puncture. BMC Physiology 10: 20.
35. Tsukumo DML, Carvalho-Filho MA, Carvalheira JBC, Prada PO, et al. 2007. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56: 1986-98.
36. Sachithanandan N, Graham KL, Galic S, Honeyman JE, et al. 2011. Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes 60: 2023-31.
37. Simopoulos AP. 2011. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol 44: 203-15.
38. Rival T, Cinq-Frais C, Silva-Sifontes S, Garcia J, et al. 2013. Alteration of plasma phospholipid fatty acid profile in patients with septic shock. Biochimie 95: 2177-81.
39. Chien J-Y, Jerng J-S, Yu C-J, Yang P-C. 2005. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33: 1688-93.
40. Lekkou A, Mouzaki A, Siagris D, Ravani I, et al. 2014. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J Crit Care 29: 723-7.
41. Vishnyakova TG, Bocharov AV, Baranova IN, Chen Z, et al. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 278: 22771-80.
42. Iwata NG, Pham M, Rizzo NO, Cheng AM, et al. 2011. Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PLoS ONE 6: e29600.
43. Mozaffarian D. 2006. Trans fatty acids-effects on systemic inflammation and endothelial function. Atheroscler 7: 29-32.
44. Pluess T-T, Hayoz D, Berger MM, Tappy L, et al. 2007. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 33: 789-97.
45. Michaeli BM, Berger M, Revelly J-P, Tappy L, et al. 2007. Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr 26: 70-7.
46. Pontes-Arruda A, Aragão AMA, Albuquerque JD. 2006. Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34: 2325-33.
47. Barbosa VM, Miles EA, Calhau C, Lafuente E, et al. 2010. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 14: R5.
48. Kelley DS, Adkins Y. 2012. Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects. Proc Nutr Soc 71: 322-31.
49. Shapiro H, Lev S, Cohen J, Singer P. 2009. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition 25: 981-97.
50. Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, et al. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via Toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837-47.
51. Liu Y, Hultén LM, Wiklund O. 1997. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 17: 317-23.
52. Prunet C, Montange T, Véjux A, Laubriet A, et al. 2006. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 69: 359-73.
53. Li AC, Glass CK. 2002. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235-42.
54. Delporte C, Van Antwerpen P, Vanhamme L, Roumeguère T, et al. 2013. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm 2013: 971579.
55. Diczfalusy U, Olofsson KE, Carlsson A-M, Gong M, et al. 2009. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipid Res 50: 2258-64.
56. Park K, Scott AL. 2010. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J Leukoc Biol 88: 1081-7.
57. Rosklint T, Ohlsson BG, Wiklund O, Norén K, et al. 2002. Oxysterols induce interleukin-1β production in human macrophages. Eur J Clin Invest 32: 35-42.
58. Aye ILMH, Waddell BJ, Mark PJ, Keelan JA. 2012. Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-κB. Mol Hum Reprod 18: 341-53.
59. Chávez-Sánchez L, Garza-Reyes MG, Espinosa-Luna JE, Chávez-Rueda K, et al. 2014. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans. Hum Immunol 75: 322-9.
60. Huang J-D, Amaral J, Lee JW, Rodriguez IR. 2014. 7-Ketocholesterol-induced inflammation signals mostly through the TLR4 receptor both in vitro and in vivo. PLoS ONE 9: e100985.
61. Morello F, Saglio E, Noghero A, Schiavone D, et al. 2009. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 207: 38-44.
62. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, et al. 2008. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409: 349-55.
63. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-61.
64. Phillips JE, Geng Y-J, Mason RP. 2001. 7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells. Atherosclerosis 159: 125-35.
65. Berthier A, Lemaire-Ewing S, Prunet C, Monier S, et al. 2004. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 11: 897-905.
66. Shentu TP, Titushkin I, Singh DK, Gooch KJ, et al. 2010. oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation. Am J Physiol Cell Physiol 299: C218-29.
67. Ragot K, Delmas D, Athias A, Nury T, et al. 2011. α-Tocopherol impairs 7-ketocholesterol-induced caspase-3-dependent apoptosis involving GSK-3 activation and Mcl-1 degradation on 158N murine oligodendrocytes. Chem Phys Lipids 164: 469-78.
68. Rentero C, Zech T, Quinn CM, Engelhardt K, et al. 2008. Functional implications of plasma membrane condensation for T cell activation. PLoS ONE 3: e2262.
69. Brigelius-Flohé R. 2009. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med 46: 543-54.
70. Asehnoune K, Strassheim D, Mitra S, Kim JY, et al. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J Immunol 172: 2522-9.
71. Godbout JP, Berg BM, Kelley KW, Johnson RW. 2004. α-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol 149: 101-9.
72. Duan W, Zhou J, Zhang S, Zhao K, et al. 2011. ESeroS-GS modulates lipopolysaccharide-induced macrophage activation by impairing the assembly of TLR-4 complexes in lipid rafts. Biochim Biophys Acta 1813: 772-83.
73. Di Mascio P, Murphy ME, Sies H. 1991. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53: 194S-200S.
74. Marquardt D, Williams JA, Kučerka N, Atkinson J, et al. 2013. Tocopherol activity correlates with its location in a membrane: a new perspective on the antioxidant vitamin E. J Am Chem Soc 135: 7523-33.
75. Bitew T, Sveen CE, Heyne B, Zaremberg V. 2010. Vitamin E prevents lipid raft modifications induced by an anti-cancer lysophospholipid and abolishes a Yap1-mediated stress response in yeast. J Biol Chem 285: 25731-42.
76. Royer M-C, Lemaire-Ewing S, Desrumaux C, Monier S, et al. 2009. 7-Ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E. J Biol Chem 284: 15826-34.
77. Muddana HS, Chiang HH, Butler PJ. 2012. Tuning membrane phase separation using nonlipid amphiphiles. Biophys J 102: 489-97.
78. Weatherill AR, Lee JY, Zhao L, Lemay DG, et al. 2005. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through T LR4. J Immunol 174: 5390-7.
79. Okada Y, Tsuzuki Y, Sato H, Narimatsu K, et al. 2013. Trans fatty acids exacerbate dextran sodium sulphate-induced colitis by promoting the up-regulation of macrophage-derived proinflammatory cytokines involved in T helper 17 cell polarization. Clin Exp Immunol 174: 459-71.
80. Yang X, Sheng W, Sun GY, Lee JC-M. 2011. Effects of fatty acid unsaturation numbers on membrane fluidity andα-secretase-dependent amyloid precursor protein processing. Neurochem Int 58: 321-9.
81. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. 2008. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16: 1248-55.
82. Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, et al. 2012. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 53: 2002-13.
83. Murumalla RK, Gunasekaran MK, Padhan JK, Bencharif K, et al. 2012. Fatty acids do not pay the toll: effect of SFA and PUFA on human adipose tissue and mature adipocytes inflammation. Lipids Health Dis 11: 175.
84. Coquerel D, Kušíková E, Mulder P, Coëffier M, et al. 2013. Omega-3 polyunsaturated fatty acids delay the progression of endotoxic shock-induced myocardial dysfunction. Inflammation 36: 932-40.
85. Martins de Lima T, Gorjão R, Hatanaka E, Cury-Boaventura MF, et al. 2007. Mechanisms by which fatty acids regulate leucocyte function. Clin Sci 113: 65-77.
86. Wassall SR, Stillwell W. 2008. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids 153: 57-63.
87. Calder PC. 2015. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851: 469-84.
88. Stulnig TM, Huber J, Leitinger N, Imre E-M, et al. 2001. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 276: 37335-40.
89. Ma DWL, Seo J, Davidson LA, Callaway ES, et al. 2004. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 18: 1040-2.
90. Li Q, Zhang Q, Wang M, Zhao S, et al. 2007. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 89: 169-77.
91. Rogers KR, Kikawa KD, Mouradian M, Hernandez K, et al. 2010. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 31: 1523-30.
92. Corsetto PA, Cremona A, Montorfano G, Jovenitti IE, et al. 2012. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation. Cell Biochem Biophys 64: 45-59.
93. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, et al. 2008. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 105: 296-307.
94. Shaikh SR, Dumaual AC, Castillo A, LoCascio D, et al. 2004. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study. Biophys J 87: 1752-66.
95. Tangney CC, Rasmussen HE. 2013. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep 15: 324.
96. Youn HS, Saitoh SI, Miyake K, Hwang DH. 2006. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72: 62-9.
97. Capiralla H, Vingtdeux V, Zhao H, Sankowski R, et al. 2012. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J Neurochem 120: 461-72.
98. Victor VM, Rocha M, De la Fuente M. 2004. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4: 327-47.
99. Di Meo F, Lemaur V, Cornil J, Lazzaroni R, et al. 2013. Free radical scavenging by natural polyphenols: atom versus electron transfer. J Phys Chem A 117: 2082-92.
100. Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, et al. 2005. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin Dev Immunol 12: 19-25.
101. Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, et al. 2003. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic Biol Med 34: 84-92.
102. Košinová P, Berka K, Wykes M, Otyepka M, et al. 2012. Positioning of antioxidant quercetin and its metabolites in lipid bilayer membranes: implication for their lipid-peroxidation inhibition. J Phys Chem B 116: 1309-18.
103. Kaneko M, Takimoto H, Sugiyama T, Seki Y, et al. 2008. Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors. Immunopharmacol Immunotoxicol 30: 867-82.
104. Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, et al. 2013. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19: 6064-93.
105. Basnet P, Skalko-Basnet N. 2011. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16: 4567-98.
106. Olkkonen VM, Hynynen R. 2009. Interactions of oxysterols with membranes and proteins. Mol Aspects Med 30: 123-33.
107. Tabas I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110: 905-11.
108. Gaus K, Gratton E, Kable EPW, Jones AS, et al. 2003. Visualizing lipid structure and raft domains in living cells with two-photon microscopy. PNAS 100: 15554-9.
109. Björkbom A, Ramstedt B, Slotte JP. 2007. Phosphatidylcholine and sphingomyelin containing an elaidoyl fatty acid can form cholesterol-rich lateral domains in bilayer membranes. Biochim Biophys Acta 1768: 1839-47.
110. Massey JB, Pownall HJ. 2006. Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry 45: 10747-58.
111. Olsen BN, Schlesinger PH, Ory DS, Baker NA. 2011. 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys J 100: 948-56.
112. Atkinson J, Harroun T, Wassall SR, Stillwell W, et al. 2010. The location and behavior of α-tocopherol in membranes. Mol Nutr Food Res 54: 641-51.
113. Lemaire-Ewing S, Desrumaux C, Néel D, Lagrost L. 2010. Vitamin E transport, membrane incorporation and cell metabolism: is α-tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res 54: 631-40.
114. Zhu X, Lee J-Y, Timmins JM, Brown JM, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 283: 22930-41.
115. Wang Z, Liu D, Wang F, Liu S, et al. 2012. Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling. Br J Nutr 107: 229-41.
116. Honda KL, Lamon-Fava S, Matthan NR, Wu D, et al. 2014. EPA and DHA exposure alters the inflammatory response but not the surface expression of Toll-like receptor 4 in macrophages. Lipids 50: 121-9
117. Weldon SM, Mullen AC, Loscher CE, Hurley LA, et al. 2007. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18: 250-8.
118. Norris PC, Dennis EA. 2012. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci USA 109: 8517-22.
119. Bak M-J, Truong VL, Kang H-S, Jun M, et al. 2013. Anti-inflammatory effect of procyanidins from wild grape (Vitis amurensis) seeds in LPS-induced RAW 264.7 cells. Oxid Med Cell Longev 2013: 409321.
120. Kim G-Y, Kim K-H, Lee S-H, Yoon M-S, et al. 2005. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-κB as potential targets. J Immunol 174: 8116-24.